Presentation to International Liver Conference 14 January 20146 November 2013 by Justine Bednorz Presentation to International Liver Conference
Presentation to Australia Biotech Invest 2013 12 October 201628 October 2013 by Justine Bednorz Presentation to Australia Biotech Invest 2013
Biotron to Present at Australia Biotech Invest 2013 28 October 2013 by Justine Bednorz Biotron to Present at Australia Biotech Invest 2013
BIT225 Enhances Anti-viral Activity In HIV/HCV Genotype 3 Co-infected Patients; Phase 2 Data To Be Presented At Leading International Liver Meeting 25 October 2013 by Justine Bednorz BIT225 Enhances Anti-viral Activity In HIV/HCV Genotype 3 Co-infected Patients; Phase 2 Data To Be Presented At Leading International Liver Meeting
Quarterly Report 30 September 2013 21 October 2013 by Justine Bednorz Quarterly Report 30 September 2013
Annual Report for year ended 30 June 2013 and Notice of Annual General Meeting 10 October 2013 by Justine Bednorz Annual Report for year ended 30 June 2013 and Notice of Annual General Meeting
Annual report for the year ended 30 June 2013 10 October 2013 by Justine Bednorz Annual Report for the year ended 30 June 2013
Shareholder update – August edition of BITNews 16 August 2013 by Justine Bednorz August 2013 edition of BITNews
BIT225 Capsule Formulation Trial Completed 14 August 2013 by Justine Bednorz BIT225 Capsule Formulation Trial Completed
Patient Enrolment in Phase 2 BIT225 Co-infected Study Completed 31 July 2013 by Justine Bednorz Patient Enrolment In Phase 2 BIT225 Co-infected Study Completed